SSKN — STRATA Skin Sciences Income Statement
0.000.00%
Last trade - 00:00- $1.00m
- $8.44m
- $30.70m
Annual income statement for STRATA Skin Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30 | 36.2 | 33.4 | 33.6 | 30.7 |
| Cost of Revenue | |||||
| Gross Profit | 19.9 | 21.8 | 18.5 | 19.1 | 17.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32.4 | 40.8 | 42.9 | 42.8 | 35.4 |
| Operating Profit | -2.37 | -4.65 | -9.51 | -9.26 | -4.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.67 | -5.49 | -10.9 | -10.3 | -6.25 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.71 | -5.55 | -10.8 | -10.1 | -6.26 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.71 | -5.55 | -10.8 | -10.1 | -6.26 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.71 | -5.55 | -10.8 | -10.1 | -6.26 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.21 | -1.59 | -2.49 | -1.95 | -1.49 |